JTC Employer Solutions Trustee’s Matinas BioPharma MTNB Stock Holding History

JTC Employer Solutions Trustee’s Portfolio MTNB Stock Details MTNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-775,000	Closed	-$72K	–	335
2024 Q3	$72K	Buy	775,000 +759,500	+4,900%	+$4.83M	﹤0.01%	226
2024 Q2	$123K	Hold	15,500	–	–	0.01%	169
2024 Q1	$222K	Hold	15,500	–	–	0.01%	127
2023 Q4	$176K	Hold	15,500	–	–	0.02%	142
2023 Q3	$101K	Hold	15,500	–	–	0.01%	189
2023 Q2	$275K	Hold	15,500	–	–	0.03%	102
2023 Q1	$358K	Hold	15,500	–	–	0.04%	94
2022 Q4	$384K	Hold	15,500	–	–	0.03%	88
2022 Q3	$508K	Hold	15,500	–	–	0.08%	67
2022 Q2	$630K	Hold	15,500	–	–	0.08%	53
2022 Q1	$632K	Hold	15,500	–	–	0.07%	60
2021 Q4	$779K	Hold	15,500	–	–	0.1%	56
2021 Q3	$1M	Hold	15,500	–	–	0.13%	47
2021 Q2	$599K	Buy	+15,500	New	+$666K	0.09%	51

Other funds holding MTNB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HIW

Holos Integrated Wealth Kennett Square, Pennsylvania $214M AUM 14.99% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

JTC Employer Solutions Trustee's MTNB Position: Q4 2024 in Review

JTC Employer Solutions Trustee sold out of Matinas BioPharma (MTNB) in Q4 2024, closing a stake of 775,000 shares — an estimated $72K sold.

JTC Employer Solutions Trustee first reported a position in MTNB in Q2 2021 and held it in 14 quarters. The position peaked at $1M in Q3 2021. 22 funds tracked by Wall St. Rank hold MTNB as of Q4 2024.

JTC Employer Solutions Trustee reported no remaining Matinas BioPharma position as of Q4 2024 after selling out during the quarter.
JTC Employer Solutions Trustee sold 775,000 Matinas BioPharma shares in Q4 2024, an estimated $72K.
JTC Employer Solutions Trustee first reported a position in Matinas BioPharma in Q2 2021 and held it in 14 quarters.
JTC Employer Solutions Trustee's Matinas BioPharma position peaked at $1M in Q3 2021.
22 funds tracked by Wall St. Rank held Matinas BioPharma as of Q4 2024.

Based on JTC Employer Solutions Trustee's 13F filing for Q4 2024, filed 13 Jan 2025.